In a groundbreaking move, China's National Healthcare Security Administration has announced updated pricing guidelines that introduce over 100 new treatment procedures. These changes aim to expand access to cutting-edge medical technologies across the Chinese mainland.
One of the most notable updates is the cost reduction for artificial heart implantation surgery, which has dropped by 30% from about 1 million yuan (roughly $140,000) to 700,000 yuan. The revised policies, achieved through standardized pricing and closer cooperation with domestic device manufacturers, also cover advanced treatments such as proton radiation therapy, cochlear implants, artificial larynx devices, and brain-computer interface technologies. Earlier, a national procurement program cut cochlear implant prices by 80% via bulk purchasing, reducing the cost from over 200,000 yuan to just 50,000 yuan per unit.
This strategic reform reflects the Chinese mainland's commitment to making life-saving and innovative treatments more accessible. By lowering costs and promoting efficiency in the public healthcare system, these measures pave the way for improved patient care and increased innovation. 🚀💡
Reference(s):
China cuts high-tech medical costs via new pricing guidelines
cgtn.com
